Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, June 8, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
admin
-
June 4, 2025
Latest Pharma-News
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
admin
-
June 4, 2025
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
Novartis ligelizumab (QGE031) more effective than Xolair®(omalizumab) at inhibiting immunoglobulin E pathway responsible for chronic spontaneous urticaria
admin
-
January 13, 2020
0
Latest Pharma-News
Bayer and Evotec form a new strategic alliance focusing on the treatment of polycystic ovary syndrome
admin
-
January 13, 2020
0
Latest Pharma-News
Almirall signs a deliberate agreement with 23andMe to license rights of a bispecific monoclonal antibody designed to blocks all three isoforms of IL-36 cytokine
admin
-
January 10, 2020
0
Latest Pharma-News
Hikma and Arecor announce exclusive agreement to co-develop a new, ready-to-use injectable medicine in the US using Arestat™ technology
admin
-
January 10, 2020
0
Latest Pharma-News
Bayer and Exscientia collaborate to influence the potential of artificial intelligence(AI) in cardiovascular and oncology drug discovery
admin
-
January 10, 2020
0
Latest Pharma-News
FDA approves Blueprint Medicines Ayvakit (avapritinib) ,first targeted therapy to treat a rare mutation in patients with Unresectable or Metastatic PDGFRA Exon 18...
admin
-
January 10, 2020
0
Latest Pharma-News
Daiichi Sankyo ENHERTU® is Now Available in the U.S. for the HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based...
admin
-
January 9, 2020
0
Latest Pharma-News
FDA approves less invasive surgical approach for Abbott’s heart pump in order to help patients avoid Open Heart Surgery
admin
-
January 9, 2020
0
Latest Pharma-News
Dietary supplements containing zinc and folic acid marketed as a treatment for male infertility does not improve pregnancy rates, sperm counts or sperm function
admin
-
January 9, 2020
0
Latest Pharma-News
BMS Completes Divestment of its oral solid, biologics, and sterile product Manufacturing and packaging Facility in Anagni, Italy
admin
-
January 9, 2020
0
Latest Pharma-News
FDA Ok’s Teleflex for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc
admin
-
January 8, 2020
0
Latest Pharma-News
Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate
admin
-
January 8, 2020
0
1
...
134
135
136
...
145
Page 135 of 145
- Advertisment -
Most Read
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
June 4, 2025
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
June 4, 2025
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025